Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis.

Axel NierhausGiorgio BerlotDetlef Kindgen-MillesEckhard MüllerMassimo Girardis

Published in: Annals of intensive care (2020)

Two distinct populations that may benefit most from Pentaglobin therapy are described in this review. However, further clinical evidence is required to strengthen support for the recommendations given here regarding timing, duration and dosage of treatment.

Keyphrases

healthcare
primary care
acute kidney injury
intensive care unit
stem cells
clinical practice
septic shock
bone marrow